Concepedia

Publication | Open Access

Phase I study of phenylacetate administered twice daily to patients with cancer

DOIFull Paper Access

129

Citations

22

References

1995

Year

Alain Thibault, Dvorit Samid, Michael R. Cooper, William D. Figg, A Tompkins, Nicholas J. Patronas, Donna Headlee, David Köhler, David Venzon, Charles E. Myers
Cancer

Abstract

Phenylacetate administered at a dose of 125 mg/kg twice daily for 2 consecutive weeks is well tolerated. High grade gliomas and advanced prostate cancer are reasonable targets for Phase II clinical trials.

References

YearCitations

Page 1